2025 International Congress Archives

Saccadic mask-induced inhibition in Parkinson’s disease

P. Daye, T. de Araujo, H. Ciupe, A. Ramirez-Zamora, C. de Hemptinne, P. Pouget (Ottignies-Louvain-la-Neuve, Belgium)
Safety and Effectiveness of Co-careldopa for Motor Recovery in Post-Stroke Patients: A Systematic Review

A. Younas, M. Qadri, R. Noor, T. Khan, M. Anwar, I. Shahid, HA. Azam Raja, A. Munir, M. Shabih, SH. Ali Inam (Lahore, Pakistan)
Safety and Efficacy of a Wrist-Worn Vibratory Stimulator for Upper Limb Tremor Reduction in Essential Tremor (ULTRE): A Randomized, Controlled Trial

F. Nahab, H. Kim, S. Nekkanti, A. Davanzo, D. Carballo, K. Winterfeldt, L. Shih, R. Elble (La Jolla, USA)
Safety and tolerability of overnight switching from Eetacapone to Opicapone in fluctuating Parkinson’s disease: An open-label preliminary trial in Koreans

M. Park, J. An (Daegu, Republic of Korea)
Safety Profile of Opicapone in Elderly and Very Elderly Population

D. Lopes, I. Peixoto, D. Martins, H. Brigas, H. Gama, J. Holenz (Coronado, Portugal)
Safety, Feasibility, and Effects of Time-Restricted Eating in Early-Stage Huntington’s Disease: Preliminary Analysis of a Clinical Pilot Trial

R. Wells, L. Neilson, A. Hiller (Portland, USA)
Safety, Tolerability and Pharmacokinetics of a Novel Oral OGA Inhibitor (FNP-223) First-in-Human Phase 1 Study

R. Pokorny, J M. Ryan, K. Abd-Elaziz, C. Varona, M. Schneider, C. Wiessner, J F. Stallaert, B. Permanne, A. Quattropani, D. Beher (Lausanne, Switzerland)
Safety, Tolerability, and Preliminary Efficacy of NouvNeu001 for the Treatment of Advanced Parkinson’s Disease: A Multi-center, Open Label, Phase 1 Study

M. Cai, J. Wei, X. Ren, R. Yan, H. Chen, N. Xiong (Chengdu, China)
Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of Vent-02, a Novel CNS-Penetrant NLRP3 Inhibitor for the Treatment of Parkinson’s Disease

A. Matta, X. Valencia, L. Warner, K. Pike, C. Winters, L. Smidt, M. Moerland, O. Spiegelstein (Waltham, USA)
Safinamide as an Adjunct Therapy for Motor Symptoms and ON-Time Extension in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

A. Fornari Caprara, J. Pitton Rissardo (Camden, USA)
Salivary Biomarkers in Parkinson’s Disease: A Follow-Up Study

MI. de Bartolo, D. Belvisi, E. Patricolo, M. Costanzo, C. Cutrona, F. Aiello, G. Leodori, A. Conte, G. Fabbrini, A. Berardelli, G. Vivacqua (Rome, Italy)
SCA27B, an Elusive Diagnosis with Effective Symptomatic Treatment: Two Cases of Late-Onset Progressive and Episodic Cerebellar Ataxia

J. Yomtoob, L. Morse, I. Keller Sarmiento, L. Kinsley, P. Opal, N. Mencacci (Chicago, USA)
Scans Without Evidence of Dopamine Deficiency (SWEDD) in Early-Onset Parkinson’s Disease: Comprehensive Clinical Analysis

A. Zare Dehnavi, C. Piat, A. Mullan, P. Turcano, E. Camerucci, M. Derhab, R. Savica (Rochester, USA)
Schindler Disease (a Rare Autosomal Recessive Lysosomal Storage Disorder)

SH. Elgamal, E. Fahmy, M. Ragab (Kafrelsheikh, Egypt)
Scopolamine-induced Tardive Dyskinesia: A Case Report

H. Deville, M. Christie (Houston, USA)
Screening for GBA1 p.K198E PD-Risk Variant in Latin America

J. Ramchandra, E. Waldo, L. Santiago, TP. Leal, T. Lopez-Gonzalez, M. Inca Martinez, C. Velez-Pardo, D. Pineda, M. Jimenez-Del-Rio, F. Lopera, S. Moreno, O. Buritica, J. Orozco, B. Muñoz Ospina, M. Camacho, G. Arboleda, H. Arboleda, O. Bernal, CE. Arboleda-Bustos, IF. Mata (Cleveland, USA)
Screening for Genetic Forms in Non-focal Dystonia Patients in Russian Population.

L. Zaripova, A. Protopopova, N. Abramycheva, E. Fedotova, S. Illarioshkin (Moscow, Russian Federation)
Screening for Neuronal Synuclein Disease (NSD) using cerebrospinal fluid (CSF) in the Parkinson Progression Marker Initiative (PPMI)

J. Dimos, B. Mcmahon, L. Lemon, A. Siderowf, T. Simuni, C. Tanner, K. Marek, C. Coffey, T. Foroud, L. Chahine, E. Brown, T. Tropea, M. Kuhl, A. Bright, M. Totten, G. Antonopoulos, L. Heathers (New Haven, USA)
Seasonal Variations in Emergency Department Admissions Among Parkinson’s Disease Patients: A North-South Comparative Analysis

S. Vallamkonda, C. Wiedner, B. Westbrook, N. Kakos, C. Hinds, M. Barnes, E. Madewell, M. Metcalf, R. Irvine, A. Menta, P. Bhaya, D. Petrosyan, A. Fajayan, O. Hofheinz, J. Passarelli, J. Kong, A. Benchouia, M. Muppirala, R. Bernal, J. Himali, A. Hohler, O. Vaou (San Antonio, USA)
Secular trends and survival of Parkinson’s disease and other forms of parkinsonism in the United Kingdom

S. Gandhi, K. Grosset, P. Iruthayaraj, R. Gravesande, L. Lee, C. Doyle, Y. Ben-Shlomo, D. Grosset (Glasgow, United Kingdom)
Seed amplification assay detects alpha-synuclein in cerebrospinal fluid in pre- and symptomatic autosomal dominant Alzheimer’s disease

A. Ahuja, J. Ringman, K. Wong (Los Angeles, USA)
Seed-based Metabolic Networks and Time Series Variation based on Functional [18F]-FDG PET in Parkinson’s Disease

M. Ruppert-Junck, V. Heinecke, K. Steidel, L. Rüsing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjürgen, J. Fuchs, H. Müller, M. Luster, L. Timmermann, C. Eggers, D. Pedrosa (Marburg, Germany)
Semantic Memory Deficit as a Potential Risk Factor of Dementia in Isolated Rapid Eye Movement Sleep Behavior Disorder

C. Zigrand, M. Trepanier Maurais, R. Postuma, S. Joubert, I. Rouleau, JF. Gagnon (Montreal, Canada)
Semi-quantitative Evaluation of Midbrain Accumulation in 123I-FP-CIT SPECT in Parkinson’s disease and Parkinsonian Syndromes

T. Totsune, T. Baba, Y. Sugimura, H. Oizumi, H. Tanaka, T. Takahashi, M. Yoshioka, K. Nagamatsu, T. Hasegawa, A. Takeda (Sendai, Japan)
Sensitivity to Reward and Decision-Making in Functional Motor Disorder: a Case-Control Study

V. Nistico', B. Gonzalez, J. da Cuna, E. Andrenelli, M. Fiorio, M. Tinazzi, F. Morgante, A. Fotopoulou, MJ. Edwards, B. Demartini, L. Ricciardi (Milan, Italy)
Sensory sensitivities in individuals with Tics and Tourette Syndrome

R. Burke, I. Malaty (Gainesville, USA)
Sensory-motor striatum iron accumulation in patients with isolated rapid eye movement sleep behavior disorder and its correlation with processing speed performance

C. Garcia-Vicente, I. Roura, J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, N. Bargalló, M. Serradell, C. Gaig, G. Mayà, A. Montini, C. Junqué, A. Iranzo, B. Segura (Madrid, Spain)
Serum based estimations of CFAH, Gelsolin, CNDP1 and DKK3 levels suggest involvement of multiple pathways in pathogenesis of Parkinson’s disease.

P. Alladi, S. Choudhury, H. Jyothi, R. Bhavani, V. Holla, A. Mahadevan, N. Kamble, P. Pal, R. YADAV. (Bengaluru, India)
Seven-year follow-up of clinical and neurophysiological features in essential tremor

L. Angelini, S. Grandolfo, D. Birreci, D. Costa, M. de Riggi, A. Martini, S. Aloisio, A. Cannavacciuolo, S. Agkun, G. Paparella, M. Bologna (Pozzilli IS, Italy)
Severe Anti-NMDAR Encephalitis After the Covid 19 Cross-vaccination in three young women

K. Methawasin, P. Tungkiatsilp, C. Suthamdireklap, M. Jaisa-Aad (Nakhon Nayok, Thailand)
Severe Dopaminergic Deficits in Early Stage Genetically-Confirmed Perry Syndrome

E. Roddy, V. Holiday, P. Hedera (Louisville, USA)
Sex Differences for Autopsy-Confirmed Prodromal Lewy Body Dementia

F. Dino, L. Gunn-Sandell, A. Tsai, D. Carter, Y. Wang, E. Bayram (Aurora, USA)
Sex differences in prodromal Parkinson’s disease (PD)

K. Atterling Brolin, S. Waters, H. Chohan, B. Huxford, S. Meyer, L. Smith, A. Shahid, A. Kuri, J. Bestwick, R. Benabderrazik, R. Lathey, E. Pablo Fernandez, L. Pérez-Carbonell, C. Simonet, A. Schrag, A. Noyce (London, United Kingdom)
Sex differences in regional densities of Lewy body pathology

C. Tremblay, S. Chiu, G. Serrano, C. Adler, H. Shill, E. Driver-Dunckley, S. Mehta, C. Belden, D. Shprecher, Y. Zeighami, M. Dadar, A. Atri, T. Beach, P. Choudhury (Montreal, Canada)
Sex Differences in α-Synuclein Seed Amplification Assay Parameters and Longitudinal Clinical Subtypes of Parkinson’s Disease

SM. Fereshtehnejad, J. Lökk (TORONTO, Canada)
Sex specific role of dyslipidemia and statin use in Parkinson’s disease pathogenesis

K. Tsutsumi, E. Shah, S. Isfahani (Orange, USA)
Sex variations in non-motor symptoms (pain, fatigue, and nausea) in Parkinson’s disease patients: An analysis from the Mexican Parkinson’s Research Network

A. Solari-Capra, A. Fierro-Ruiz, A. Steven-García, P. Reyes-Pérez, A. Lázaro-Figueroa, E. Morelos-Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, K. Salinas-Barboza, Y. Matuk-Pérez, N. Gandarilla-Martínez, U. Caballero-Sánchez, P. Montés-Alcántara, V. Flores-Ocampo, I. Espinosa-Méndez, A. Zayas-Del Mora, E. Gaspar-Martínez, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, M. Rentería, A. Medina-Rivera, A. Ruiz-Contreras (Querétaro, Mexico)
Sex-Based Differences in Perioperative Risks and Outcomes in Deep Brain Stimulation for Parkinson’s Disease: A Decade-Long ACS-NSQIP Analysis

K. Heintzelman, A. Khan, K. Pyle, J. Diaz-Riaño, A. Memon (Morgantown, USA)
Sex-Dependent Associations Between PGLYRP2 Variants and Parkinson’s Disease Across Diverse Ancestries

HM. Chaparro-Solano, CL. Avila, V. Quintana-Peña, KA. Brolin (Cleveland, USA)
Sex-specific genetic architecture of autosomal risk for Parkinson’s Disease: from the Global Parkinson’s Genetics Program

GP2. Parkisnon'S_genetics_program (Bethesda, USA)
Sexual Health Decline in Women with Parkinson’s Disease: A Two-Year Follow-Up Study

T. Silva, K. Nobrega, ME. Piemonte (Sao Paulo, Brazil)
Shaking, Not Stirred: An Atypical Case of Propriospinal Myoclonus

S. Khurana, A. Prabhu (Philadelphia, USA)
Simple and Effective OnabotulinumtoxinA Injection Technique for Hemifacial Spasm

K. Fungpunyaroj, P. Chairangsaris (Bangkok, Thailand)
Simple linear measurements of the putamen reliably differentiate MSA from other parkinsonian disorders on MRI.

T. Rohringer, V. Lam Shin-Cheung, P. Alcaide-Leon (Toronto, Canada)
Single- and Multi-Unit Activity in STN Provides Enhanced Insight into Speech-Related Neural Dynamics in Parkinson’s Patients

Z. Jourahmad, A. Rohl, J. Greenlee (Iowa City, USA)
Single-Center Real-World Validation of Cognitive vs. Motor-Based Fall Prediction Models in Parkinson’s Disease

S. Anis, E. Zimmerman, H. Fernandez, A. Rosenfeldt, J. Alberts (Cleveland, USA)
SL-START: A Multicentre Observational Study of Sublingual Apomorphine Titration and Usage Schemes in Routine Practice

J. Kassubek, P. Themann, H. Brigas, C. Maganete, G. Harrison-Jones, I. Pijuan Jiménez (Ulm, Germany)
Sleep Circadian Rhythms and Brain Disorders: A Large Prospective Cohort and Mendelian randomization Study

M. Zhong, J. Liu, Y. Li (shanghai, China)
Sleep Dysfunction in Parkinson’s Disease and Essential Tremors

A. Elgendi, M. Salim, R. Bedros, A. Mansour, A. Shalash (Cairo, Egypt)
Sleep Quality among Lewy Body Dementia Family Caregivers

W. Ayele, J. Hemm, S. Mitchell Chen, E. Stevens, A. Taylor, K. Fargo, D. Mariani, S. Seshadri, C. Bentley, T. Manak, A. Miller, C. Pensyl, C. Pierce, M. Voss, B. Ouyang, J. Chodosh, J. Fleisher (Chicago, USA)
Sleep-wake Alterations are Associated with a Decreased DTI-ALPS, a Marker of Perivascular Glymphatic Functioning, in Patients with Isolated REM Sleep Behavior Disorder

I. Roura, J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, C. Garcia-Vicente, N. Bargalló, M. Serradell, C. Gaig, G. Mayà, A. Montini, J. Madrir, M. Rol, A. Adan, C. Junqué, A. Iranzo, B. Segura (Barcelona, Spain)
Sleep-wake modulation of subthalamic activity in patients with Parkinson’s disease and conventional or adaptive deep brain stimulation

L. Caffi, R. Habib, S. Bonvegna, M. Pilleri, G. Pezzoli, C. Palmisano, A. Mazzoni, IU. Isaias (Milan, Italy)
Smartphone-based digital assessments in the LUMA trial of BIIB122 for early-stage Parkinson’s disease

R. Llorens Arenas, J. Edgerton, E. Bartholomé, S. Belachew, M. Gifford, J. Guo, B. Hersh, D. Jennings, C. Kanzler, E. Koca, M. Pang, O. Reyes, C. Shen, M. Wald, N. Woody, C. Mazzá (Cambridge, USA)
Smoking and Genetic Interactions in Parkinson’s Disease

JDJ. Wang, LL. Chan, E. Ng, K. Prakash, WL. Au, L. Tan, EK. Tan (Singapore, Singapore)
Solengepras: An Investigational Therapy with Potential Benefits on Functional and Non-Motor Measures in Parkinson’s Disease (PD)

S. Isaacson, K. Chou, H. Sarva, S. Merchant, C. Scholl, M. Charles, N. Brice, L. Dawson, M. Carlton, S. Vaidya, K. Kieburtz, R. Hauser, A. Ellenbogen (Ann Arbor, USA)
Spastic Paraplegia as a Novel Phenotype in Late Adulthood Onset POLG Disease: A Pathophysiological Continuum?

S. Jha, M. Jog (London, Canada)
Spatial Metabolic Covariance Networks in PSP: Implications for Symptomatology and their Neural Basis

B. Wang, W. Luo (Hangzhou, China)
Spatial Multi-Omics Identifies Early Synaptic Pruning and Context-Specific Dopaminergic Vulnerability in Synucleinopathies

S. Rumpf, F. Strübing, K. Nalbach, S. Lichtenthaler, C. Vargiu, P. Parchi, G. Höglinger, J. Herms, T. Koeglsperger (Munich, Germany)
Spatiotemporal Gait Norms in Essential Tremor

A. Bin Khunayfir, B. Petko, R. Tripathi, C. Lin, S. Factor, L. Mckay, C. Esper (Atlanta, USA)
Spatiotemporal Gait Norms in Moderate-to-Advanced Parkinson’s Disease

K. Miller, R. Tripathi, S. Solano, S. Factor, J. Mckay, C. Esper (Atlanta, USA)
Spatiotemporal Neural Dynamics of the Cerebellum Underlie Differential Therapeutic Outcomes in Essential Tremor Subtypes

MK. Pan, LY. Chen (Taipei, Taiwan)
Specialized palliative care for advanced Parkinsonian syndromes: bridging the gap

K. Cantu Flores, E. Mcrae, K. Waldmann, R. Kline, V. Bruno (Calgary, Canada)
Spectrum and Evolution of Movement Disorder Phenomenology in a Pediatric Powassan Encephalitis Case Series

R. Lindsay, K. Yang, V. Quiroz, R. Srouji, D. Ebrahimi-Fakhari (Calgary, Canada)
Spectrum of Movement Disorders Associated With Autoimmune Thyroid Disease

A. Maheshwary, S. Anderson, N. Prakash (Farmington, USA)
Speech and Swallowing Function Following Deep Brain Stimulation for Dystonia?

N. Walker-Pizarro, H. Kamu, J. Hilliard, K. Hegland, N. Herndon, S. Gaber, M. Okun, A. Ramirez-Zamora (Gainesville, USA)
Spinocerebellar Ataxia 15: The first reported case of SCA15 in Asia secondary to ITPR1 gene mutation

M. Fontanilla, P. Cataniag, M. Orteza, P. Quitasol (Baguio City, Philippines)
Spinocerebellar Ataxia 17 Presenting with Childhood Seizures and Mesial Temporal Lobe Sclerosis

E. Levoir, Y. Bronstein, P. Hickey, C. Fong (Los Angeles, USA)
Spinocerebellar Ataxia Recessive Type 7 (SCAR7) in a Consanguineous Family: A Case Report

T. Ozum, O. Akcin, C. Durmaz, G. Yalcin Cakmakli, B. Elibol (Ankara, Turkey)
Spinocerebellar Ataxia Type 17 First Reported Case in Northern Mexico

S. Murillo Quintana, D. Sánchez Galván, J. Mejía Chávez, S. Flores Casas, L. Hernández Salomón (Torreón, Coahuila, Mexico)
Spinocerebellar Ataxia Type 40 (SCA-40) with a Novel Mutation in an Indian Female: A Case Report

A. Mehta, P. Hiremath, M. Javali, P. R, L. Priya, P. Acharya (Bengaluru, India)
Spinocerebellar Ataxia Type 7: First Report of Clinical and Molecular Findings of Two Family in Senegal – West Africa (Video Cases)

M. Fall (Dakar, Senegal)
Split tablet dosing of Levodopa/Carbidopa/Entacapone 100mg/25mg/200mg in treating Chinese patients with early Parkinson’s disease: a single-center, prospective cohort study

XY. Cheng, CJ. Mao, CF. Liu (Suzhou, China)
SREAT with Cerebellar Involvement: When Tremor Mimics Stroke – A Case report

S. Camargo-Casas, N. Rueda, S. Preciado, X. Garcia (Bogota, Colombia)
Staged Bilateral MRI-Guided Focused Ultrasound Thalamotomy in Essential Tremor a Single Institution Experience of 26 Patients

N. Pertsch, K. Sakakura, YJ. Ahn, D. Kim, J. Mueller, L. Chiu, J. Varela, S. Patel, J. Pearce, N. Patel, S. Sani (Chicago, USA)
Staging Disease Progression from Prodromal to Overt Stage of Alpha-synucleinopathies

D. Arnaldi, M. Roascio, E. Antelmi, F. Biscarini, L. Baldelli, V. Brunetti, E. Capriglia, E. Casaglia, A. Castelnuovo, G. Della Marca, L. Ferini-Strambi, R. Ferri, M. Figorilli, A. Galbiati, B. Guarnieri, D. Hoxhaj, F. Di Laudo, C. Liguori, S. Marelli, P. Mattioli, M. Mulas, B. Orso, M. Pardini, F. Pizza, F. Placidi, G. Plazzi, F. Provini, L. Sambati, M. Puligheddu, G. Arnulfo (Genova, Italy)
Static Posturography Changes Following Unilateral MRI-Guided High Frequency Focused Ultrasound Thalamotomy – case series

R. Tripathi, J. Powell, S. Nkomboni, J. Mckay, C. Esper (Atlanta, USA)
Status Dystonicus is a Distinct State Characterized by Pallidal Beta-band Activity

A. Balachandar, L. Vogt, K. Mithani, S. Coleman, M. Ebden, A. Leblanc-Miller, S. Breitbart, A. Fasano, C. Gorodetsky, G. Ibrahim (Toronto, Canada)
Stepping backwards to move forward A case study on novel PT interventions for DLB

K. Vasher, A. Boddy (Loma Linda, USA)
Stereotypy and other Movement Disorders Following Osmotic Demyelinating Syndrome: a case report

K. Taracatac, P. Cataniag, R. San Juan, M. Fontanilla, M. Sarfati (Baguio City, Philippines)
Stiff person syndrome: about a Tunisian case series

YO. Memmich, RA. Zouari, ZA. Saied, AM. Rachdi, DI. Ben Mohamed, SAM. Ben Sassi (Tunis, Tunisia)
Stimulation-Entrained Gamma-Driven Adaptive DBS Improves Motor Diary Reports of Symptom Fluctuations in Parkinson’s Disease

L. Hammer, S. Cernera, C. Oehrn, M. Shcherbakova, A. Hahn, J. Yao, O. Weiss, S. Little, P. Starr (Philadelphia, USA)
STN Iron Content Correlates with DBS Efficacy in Parkinson’s Patients: a Preliminary Study

G. Du, A. Snyder, J. Seemiller, L. Kong, P. Eslinger, J. Mcinerney, E. Farace, R. Mailman, X. Huang, S. de Jesus (Hersehy, USA)
STN-DBS Improves Motor and Cognitive Functions Associated with Increased Occipital Metabolism in PDD Patients

Q. Zhang, FT. Liu, JJ. Ge, J. Wang, JJ. Wu (Shanghai, China)
STOP-TIC Study: Strengthening Tourette Treatment Options using TMS to Improve CBIT, a randomized sham-controlled trial

J. Frey, J. Sherman, T. Mcgaughey, J. Suffridge, M. Khan, E. Reid, U. Najib, A. Wagle Shukla, A. Murray, M. Okun, IA. Malaty (Morgantown, USA)
Stratification study of alpha-synucleinopathy by body fluid biomarkers

R. Kamo, A. Okuzumi, M. Iseki, T. Hatano, N. Hattori (Tokyo, Japan)
Stretegy of self-care in patient with Parkison disease: a metasynthesis

M. Petralito, C. Tedesco, I. Milani, G. Pucciarelli, R. Caruso (Roma, Italy)
Striatal dopamine- and basal forebrain cholinergic-dependent brain metabolism and cognition in Parkinson’s disease

HS. Yoo, JH. Lee, M. Park, SJ. Ahn, JH. Lee, YH. Ryu, CH. Lyoo (Seoul, Republic of Korea)
Striatal Dysfunction in Parkinson’s Disease Progression: A 18F-9-fluoropropyl-(+)-dihydrotetrabenazine(18F-AV133) PET Study

X. Liu, G. Tamagnan, H. Qiao, J. Lu, C. Zhang, S. Liu (Beijing, China)
Stroke, Chronic Ataxia and Tremor in a Pediatric Patient with c.2137C>A Genetic Variant in CACNA1A

A. Vargas Nino, H. Alfaris, C. Gorodetsky (Toronto, Canada)
Structural changes in the retina and their correlation with the severity of non-motor symptoms in patients with Parkinson’s disease.

A. Alcocer-Salas, A. Camacho-Ordonez, M. Rodriguez-Violante, A. Cervantes-Arriaga (Mexico City, Mexico)
Study Of Epidemiological and Clinical Profile of Neurologic Wilson’s Disease from a Tertiary Care Hospital In India

A. Kumar, A. Ranjan, R. Solanke, J. Sharma, S. Kumar (Patna, India)
Study on individual differences in shoulder and hip joints during walking in patients with Parkinson’s disease

J. Ogawa, Y. Yamaguchi, K. Kakegawa, T. Matsuda, T. Kurayama (Ginza, Chuo-ku, Japan)
Studying the Influence of Genetic Variations on Functional Performance in Parkinson’s Disease

D. Moss, K. Smaller, M. Rafferty, P. Gonzalez-Latapi (Chicago, USA)
Studying the relationship between interoceptive awareness, caregiver burden, and disease perception in Parkinson’s Disease

F. Velasco-Delgado, A. Hernandez-Medrano, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante, D. Ulloa-Hernández, G. Martin-Mafud (Mexico City, Mexico)
Sub-grouping of Parkinson’s disease based on thalamic subnuclei volume

S. Haji, W. Sako, H. Haginiwa, K. Kamagata, T. Hatano, N. Hattori (Bunkyo, Japan)
Subacute Severe Dystonia in a 19-month Old Boy. A Case of Pediatric Stiff Person Syndrome (SPS)

MU. Huun, S. Wallace, SH. Nordstrand (Oslo, Norway)
Subacute Unmasking of AD-CBS Subtype

L. Farese, P. Prakash, J. Drake, S. Estrada (Providence, USA)
Subdomain-specific cognitive decline and its effect on caregiver burden in Mexican population living with Parkinson’s Disease.

G. Martin-Mafud, A. Hernández-Medrano, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante, D. Ulloa-Hernández, M. Velasco-Delgado (Mexico City, Mexico)
Subthalamic Deep Brain Stimulation Modulates Cognitive-Motor Integration in Parkinson’s Disease: Insights from a Dual-task fNIRS Study

YQ. Zhang, JP. Li, Y. Liang (Beijing, China)
Subthalamic nucleus DBS outcomes correlate with white matter tractography in Parkinson’s Disease

I. Campbell, V. Del Bene, R. Martin, C. Gonzalez, S. Brinkerhoff, M. Wade, B. Hill, H. Walker, V. Mishra (Mobile, USA)
Subthalamic Nucleus Stimulation May Suppress Both Ipsilateral and Contralateral Local-Field-Potential Magnitude

B. Chase, M. Avenali, S. Malaspina, R. Zangaglia, K. Markopoulou (Evanston, USA)
Subthalamic versus Pallidal Temporal Interference Stimulation in Parkinson’s Disease: A Pilot Study

J. Li, A. Li, C. Zhang (Shanghai, China)
Subthalamic β frequency oscillatory activity is modulated by self-paced wrist movement

P. Zhuang, X. Zhao, J. Li, Y. Zhang, Y. Hu, M. Hallett, Y. Li (Beijing, China)
Subthalamotomy and thalamotomy using MgFUS: Retrospective review of 9 years of treating Parkinson’s disease and Essential Tremor.

C. Del Toro-Pérez, R. Martínez-Fernández, E. Natera-Villalba, R. Rodriguez-Rojas, J. Pineda-Pardo, C. Gasca Salas, M. Matarazzo, JA. Obeso Inchausti (Madrid, Spain)
Successful Treatment of Hemifacial Spasm with Daxibotulinum Toxin A

HS. Lee (Sacramento, USA)
Superior cluneal neuralgia in Parkinson’s disease: frequency and clinical features.

M. Mihara, Y. Kajiyama, A. Saito, R. Satake, Y. Kutoku (Kurashiki, Japan)
Supporting Movement Disorders Specialists with Digital Tools that Integrate with their Workflows

J. Ikhile, V. Pandey (Salt Lake City, USA)
Survey of knowledge and training needs of professionals in nursing homes for Parkinson’s disease

J. Thezenas, M. Heuzé-de Raeve (Eaubonne, France)
Sustained Benefit of a Wrist-Worn Vibratory Wearable on Upper Limb Essential Tremor

H. Kim, F. Nahab, S. Nekkanti, A. Davanzo, D. Carballo, K. Winterfeldt, L. Shih, R. Elble (Cambridge, USA)
Sustained Motor Symptom Efficacy With Long-Term Levodopa–Entacapone–Carbidopa Intestinal Gel (LECIG) Treatment – Data From The ELEGANCE Interim Analysis

B. Amlani, N. Smith (Reading, United Kingdom)
Swallowing sound index analysis using electronic stethoscope and artificial intelligence for patients with Parkinson’s disease

R. Matsuyama, M. Nakamori, Y. Shimizu, O. Kikumoto, H. Maruyama (Hiroshima City, Japan)
Symptomatic Peri-Lead Oedema After Bilateral Subthalamic Nucleus Deep Brain Stimulation Surgery- Not All Cases Are Self-Limiting: A Case Series

SS. Idris, O. Parras Granero, A. Chari, M. Krueger, H. Akram, J. Hyam, T. Foltynie, L. Zrinzo, P. Limousin (London, United Kingdom)
Synchronized High Frequency Neural Oscillations as a Biomarker for Differentiating the Internal from the External Segment of the Globus Pallidus in Parkinson’s Disease

J. Aman, K. O'Neill, S. Safo, M. Hill, S. Alberico, R. Cole, L. Johnson, J. Wang, K. Domingo, L. de Almeida, S. Cooper, D. Darrow, R. Mcgovern Iii, M. Park, L. Eberly, J. Vitek (Minneapolis, USA)
Systemic Lupus Erythematosus presenting as Chorea

H. Chovatiya (Surat, India)